Processa Pharmaceuticals (PCSA) Interest & Investment Income (2012 - 2026)
Processa Pharmaceuticals (PCSA) recorded Interest & Investment Income of $13,859 in Q1 2026, up 10.1% from $12,585 a year earlier.
Powered by 
Analysis
Processa Pharmaceuticals (PCSA) Interest & Investment Income (2012 - 2026) Analysis & Trends
On a TTM basis, Processa Pharmaceuticals' Interest & Investment Income came in at $304,726 as of Mar 31, 2026, up 46.7% year-over-year; for FY2025, it was $109,491, down 45.6% from FY2024.
- Annual Interest & Investment Income has a five-year compound annual growth rate of 103.0% (FY2020 to FY2025).
- Across earlier years, Interest & Investment Income came in at $201,088 in FY2024 (-40.1%), $335,541 in FY2023 (+231.6%), $101,202 in FY2022 (+744.1%) and $11,989 in FY2021 (+277.7%).
- The Q1 2026 figure is the highest quarterly Interest & Investment Income since Q4 2024.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 306.8% in Q2 2022, against a decline of 68.0% in Q1 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Processa Pharmaceuticals | 4.33 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 13,859.00 |
| Mar 31, 2025 | 12,585.00 |
| Dec 31, 2024 | 238,132.00 |
| Sep 30, 2024 | 40,150.00 |
| Mar 31, 2024 | -83,217.00 |
| Dec 31, 2023 | 64,519.00 |
| Sep 30, 2023 | 85,661.00 |
| Dec 31, 2022 | 55,530.00 |
| Sep 30, 2022 | 36,708.00 |
| Jun 30, 2022 | 7,380.00 |
| Mar 31, 2022 | 1,583.00 |
| Dec 31, 2021 | 3,826.00 |
| Sep 30, 2021 | 1,771.00 |
| Jun 30, 2021 | 1,814.00 |
| Mar 31, 2021 | 4,940.00 |
| Dec 31, 2020 | 2,315.00 |
| Sep 30, 2020 | 12.00 |
| Jun 30, 2020 | 18.00 |
| Mar 31, 2020 | 829.00 |
| Dec 31, 2019 | 662.00 |
API Access
Processa Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PCSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "PCSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PCSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();